Severe, persistent abdominal pain (possible pancreatitis), signs of gallbladder disease, or unusual bleeding in patients taking anticoagulants warrant prompt medical evaluation
Ongoing research: Long-term studies are continuing to evaluate these potential risks
Real-world tirzepatide outcomes in PCOS
SURMOUNT-1 demonstrated average body weight reductions of 15% at the 5mg dose, 19.5% at 10mg, and 20.9% at 15mg over 72 weeks, compared to 3.1% with placebo
The timing of compounds, escalation schedules, and cycle architecture all influence outcomes
Based on user reports and third-party reviews, compounded semaglutide through Empower-partnered platforms typically runs in the range of $150$300/month, depending on dose and platform markup